Article Information
History
- April 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sharifa Nasreen1,2,
- Andrew Calzavara1,
- Maria Sundaram1,2,
- Shannon E. MacDonald3,
- Christiaan Righolt4,
- Menaka Pai5,
- Thalia Field6,
- Lily W. Zhou6,7,
- Sarah Wilson1,2,8,
- Jeffrey C. Kwong1,2,8,9,10,* and
- on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) investigators
- 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
- 2ICES, Toronto, ON, Canada
- 3Faculty of Nursing, University of Alberta, Edmonton, AB, Canada
- 4Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
- 5Department of Medicine, McMaster University, Hamilton, ON, Canada
- 6Division of Neurology, University of British Columbia, Vancouver Stroke Program, Vancouver, BC, Canada
- 7Stanford Stroke Center, Palo Alto, CA, USA
- 8Public Health Ontario, ON, Canada
- 9Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada
- 10University Health Network, Toronto, ON, Canada
- ↵*Corresponding author: Jeff Kwong, Senior Scientist, ICES, G1 06, 2075 Bayview Avenue, Toronto, Ontario, Canada, M4N 3M5, jeff.kwong{at}utoronto.ca, Phone: (416) 480-4055 x1-7665, Fax: (416) 480-6048
Posted April 04, 2021.
Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
